Nanolitre‐scale cell assays developed with droplet microarray-mass spec
A team has developed nanolitre cell assays on droplet microarrays to enable pharmacodynamic monitoring in live cells.
List view / Grid view
A team has developed nanolitre cell assays on droplet microarrays to enable pharmacodynamic monitoring in live cells.
An artificial intelligence platform has been created to enable tens of thousands of microscopy images to be generated in an hour.
KingFisher APEX is our newest instrument for automation workflows for high throughput DNA and RNA extraction. With precision handling and touch screen interface.
Using X-ray crystallography and simulations, researchers have shown that APT2 is a hybrid between a lipid carrier protein and a hydrolase.
Researchers have produced the first 3D image of the Mediator-bound pre-initiation complex, key in the regulation of gene expression.
A new imaging technique for photoreceptors has been developed by selectively blocking light used to observe the eye.
RiboMinus Bacteria 2.0 Transcriptome Isolation Kits perform efficient transcriptome enrichment from total bacterial RNA. Improve your RNA extraction from bacteria today.
A spectroscopic microscope has been developed by researchers to gather data on biological conformations faster and more accurately.
Using X-ray crystallography and cryo-electron microscopy, researchers have elucidated the structure of the SARM1 protein, a target for neurodegeneration.
A team of researchers have used microscopy techniques to monitor DNA degradation and anticancer drug release from nanostructures.
A new coarse-grained model of the complete SARS-CoV-2 virion has revealed potential new ways to combat the coronavirus.
Researchers have developed a new technique called mim-tRNAseq to measure, map and analyse tRNAs in cells, providing insight into disease.
A fluorescence imaging technique has allowed scientists to observe RNA in real time using single-molecule localisation microscopy.
With the right solution organisations can simplify their lab-based working, while ensuring the highest level of compliance with regulatory requirements.
Researchers have found that the S1/S2 cleavage of the SARS-CoV-2 Spike protein could be a potential target for COVID-19 therapeutics.